124 related articles for article (PubMed ID: 26284135)
21. Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.
Shi L; Yu B; Cai CH; Huang JD
AMB Express; 2016 Dec; 6(1):56. PubMed ID: 27558018
[TBL] [Abstract][Full Text] [Related]
22. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
Pasetti MF; Pickett TE; Levine MM; Sztein MB
Vaccine; 2000 Aug; 18(28):3208-13. PubMed ID: 10869765
[TBL] [Abstract][Full Text] [Related]
23. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
24. Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model.
Kazmierczak RA; Dhagat-Mehta B; Gulden E; Lee L; Ma L; Davis-Stober CP; Barnett AA; Chabu YC
Oncotarget; 2020 Nov; 11(44):3943-3958. PubMed ID: 33216833
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.
Yamamoto T; Sashinami H; Takaya A; Tomoyasu T; Matsui H; Kikuchi Y; Hanawa T; Kamiya S; Nakane A
Infect Immun; 2001 May; 69(5):3164-74. PubMed ID: 11292737
[TBL] [Abstract][Full Text] [Related]
26. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
27. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
Witt K; Ligtenberg MA; Conti L; Lanzardo S; Ruiu R; Wallmann T; Tufvesson-Stiller H; Chambers BJ; Rolny C; Lladser A; Lundqvist A; Cavallo F; Kiessling R
Cancer Immunol Res; 2018 Nov; 6(11):1417-1425. PubMed ID: 30143536
[TBL] [Abstract][Full Text] [Related]
28. Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice.
Zhang M; Swofford CA; Forbes NS
Int J Cancer; 2014 Aug; 135(3):647-57. PubMed ID: 24374783
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium.
Crull K; Weiss S
Exp Biol Med (Maywood); 2011 Nov; 236(11):1282-90. PubMed ID: 21987828
[TBL] [Abstract][Full Text] [Related]
30. Effect of inactivation of degS on Salmonella enterica serovar typhimurium in vitro and in vivo.
Rowley G; Stevenson A; Kormanec J; Roberts M
Infect Immun; 2005 Jan; 73(1):459-63. PubMed ID: 15618185
[TBL] [Abstract][Full Text] [Related]
31. aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant.
Felgner S; Frahm M; Kocijancic D; Rohde M; Eckweiler D; Bielecka A; Bueno E; Cava F; Abraham WR; Curtiss R; Häussler S; Erhardt M; Weiss S
mBio; 2016 Sep; 7(5):. PubMed ID: 27601574
[TBL] [Abstract][Full Text] [Related]
32. Exposure to sub-inhibitory concentrations of cefotaxime enhances the systemic colonization of Salmonella Typhimurium in BALB/c mice.
Molina-Quiroz RC; Silva CA; Molina CF; Leiva LE; Reyes-Cerpa S; Contreras I; Santiviago CA
Open Biol; 2015 Oct; 5(10):. PubMed ID: 26468132
[TBL] [Abstract][Full Text] [Related]
33. Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis.
Ikeda JS; Schmitt CK; Darnell SC; Watson PR; Bispham J; Wallis TS; Weinstein DL; Metcalf ES; Adams P; O'Connor CD; O'Brien AD
Infect Immun; 2001 May; 69(5):3021-30. PubMed ID: 11292720
[TBL] [Abstract][Full Text] [Related]
34. Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.
Tjuvajev J; Blasberg R; Luo X; Zheng LM; King I; Bermudes D
J Control Release; 2001 Jul; 74(1-3):313-5. PubMed ID: 11489512
[TBL] [Abstract][Full Text] [Related]
35. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
[TBL] [Abstract][Full Text] [Related]
36. Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection.
Fadl AA; Sha J; Klimpel GR; Olano JP; Niesel DW; Chopra AK
Infect Immun; 2005 Feb; 73(2):1081-96. PubMed ID: 15664952
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.
Zhang Y; Miwa S; Zhang N; Hoffman RM; Zhao M
Oncotarget; 2015 Feb; 6(5):2615-22. PubMed ID: 25575815
[TBL] [Abstract][Full Text] [Related]
38. Complete genome sequence of Salmonella enterica serovar Typhimurium VNP20009, a strain engineered for tumor targeting.
Broadway KM; Modise T; Jensen RV; Scharf BE
J Biotechnol; 2014 Dec; 192 Pt A():177-8. PubMed ID: 25046822
[TBL] [Abstract][Full Text] [Related]
39. Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape.
Mackie GM; Copland A; Takahashi M; Nakanishi Y; Everard I; Kato T; Oda H; Kanaya T; Ohno H; Maslowski KM
JCI Insight; 2021 Oct; 6(23):. PubMed ID: 34710062
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.
Yoon W; Yoo Y; Chae YS; Kee SH; Kim BM
Ann Oncol; 2018 Sep; 29(9):2010-2017. PubMed ID: 30016386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
